Major ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 50 Tablets (5x10) blister package, Rx Onl...

FDA Drug Recall #D-0009-2026 — Class II — September 12, 2025

Recall Summary

Recall Number D-0009-2026
Classification Class II — Moderate risk
Date Initiated September 12, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Location La Vergne, TN
Product Type Drugs
Quantity 2064 blister packs

Product Description

Major ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 50 Tablets (5x10) blister package, Rx Only, Packaged and Distributed by Major Pharmaceuticals, Indianapolis, IN 46268, USA, NDC 0904-7130-06, UPC (01)00309047130061

Reason for Recall

CGMP Deviations: Presence of N-Nitroso Desmethyl Chlorpromazine above the recommended intake limit

Distribution Pattern

Nationwide

Lot / Code Information

Lots N01943 and Lot N02025, exp. date 02/28/2026

Other Recalls from The Harvard Drug Group LLC dba Major ...

Recall # Classification Product Date
D-0011-2026 Class II Major ChlorproMAZINE Hydrochloride Tablets, USP... Sep 12, 2025
D-0012-2026 Class II Major ChlorproMAZINE Hydrochloride Tablets, USP... Sep 12, 2025
D-0013-2026 Class II Major ChlorproMAZINE Hydrochloride Tablets, USP... Sep 12, 2025
D-0010-2026 Class II Major ChlorproMAZINE Hydrochloride Tablets, USP... Sep 12, 2025
D-0625-2025 Class II Sulfamethoxazole and Trimethoprim, USP, 800 mg/... Sep 2, 2025

Frequently Asked Questions

cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.